Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 1/2
This study is looking at a new treatment that may help your immune system to attack breast cancer cells. It is for people who have breast cancer that produces a protein () called WT1.
Recruitment start: 1 February 2012
Recruitment end: 11 July 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Dixon
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 16 Jul 2014
CRUK internal database number: 8103